Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody

Therapeutic agent for cancer which comprises combination of IL-18 and molecule-targeting antibody

US Patent 11219672 · Granted Jan 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carboxylic acid derivatives that inhibit the binding of integrins to their recep2010
IFN-γ production inducing protein (IGIF, IL-18)2010
Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells2010
Vγ9Vδ2 T cell proliferation agent, method for producing activated Vγ9Vδ2 T cells2010
Cell culture and method for screening for a compound useful in the treatment or 2010
Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclona2008
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II recep2008
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II recep2007
Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclona2006
Cell culture incubating apparatus and method using the same2006
Carboxylic acid derivatives that inhibit the binding of integrins to their recep2005
Propanoic acid derivatives that inhibit the binding of integrins to their recept2004